Patents Assigned to Fresenius Medical Care Holdings, Inc.
  • Patent number: 11540739
    Abstract: A technique for determining skin sodium content using bioimpedance spectroscopy includes applying a current at a predetermined frequency to skin of a subject, measuring a voltage across the skin of the subject produced by the current, determining a resistance across the skin of the subject at the predetermined frequency using the measured voltage, and determining skin sodium content using the measured voltage.
    Type: Grant
    Filed: April 14, 2022
    Date of Patent: January 3, 2023
    Assignee: Fresenius Medical Care Holdings, Inc.
    Inventors: Fansan Zhu, Peter Kotanko
  • Patent number: 11525798
    Abstract: Methods and systems for monitoring fluid levels and electrolyte levels used in a dialysis machine. A receptacle, configured to receive a container, comprises a plurality of curved side panels and a base to form a cylindrical shaped cavity for receiving a container. Each panel includes a conductive material on its inner surface and, optionally, a shielding on its outer surface. An electronics component housed within, or near, the receptacle drives the capacitive process and interprets generated data to determine fluid levels and compositions. An alternate receptacle includes one or two coils wrapped about the container and uses induction to determine fluid level.
    Type: Grant
    Filed: February 27, 2020
    Date of Patent: December 13, 2022
    Assignee: Fresenius Medical Care Holdings, Inc.
    Inventors: Barry Neil Fulkerson, Gregory Hayes Gengarelly, Tam Nolan
  • Patent number: 11524104
    Abstract: In some embodiments, a medical system includes a dialysis machine having at least one outer surface to be disinfected at a given location, at least one disinfection sensor connected to the dialysis machine at the given location, the disinfection sensor including two or more electrode in fluid contact with the outside surface of the dialysis machine, and a conductivity sensor component in electrical contact with the two or more electrodes, the conductivity sensor component configured to send an electrical signal indicating a conductivity of a liquid on an outside surface of the dialysis machine and in contact with the two or more electrodes, a processor configured to receive the electrical signal and thereby determine a disinfection status of the given location, and a user interface configured to indicate the disinfection status of the given location.
    Type: Grant
    Filed: July 26, 2019
    Date of Patent: December 13, 2022
    Assignees: Fresenius Medical Care Holdings, Inc.
    Inventors: Martin Joseph Crnkovich, Colin Weaver, Christian Schlaeper
  • Patent number: 11524102
    Abstract: A dialysis system is provided that includes a dialysis machine and a potassium sensing device that is configured to measure the concentration of potassium in the patient's blood, in spent dialysate resulting from treating the patient, or in both. The potassium sensing device can be configured to generate a sensed value of the concentration of potassium. A control and computing unit, including a processor and a memory, is configured to receive the sensed value, compare the value with one or more values stored in the memory, and generate a control signal based on the comparison. A potassium infusion circuit uses the control signal to infuse supplemental potassium solution into the treatment dialysate, a replacement fluid, or both. The memory can include stored patient-historical and population data.
    Type: Grant
    Filed: July 24, 2019
    Date of Patent: December 13, 2022
    Assignee: FRESENIUS MEDICAL CARE HOLDINGS, INC.
    Inventors: Stephen Merchant, Roland Levin, Chris Chau, Shakil Aslam
  • Publication number: 20220370699
    Abstract: An extracorporeal blood treatment device and a method are provided for removing a secondary membrane formed on a semipermeable membrane of a dialyzer during an extracorporeal blood treatment. The extracorporeal blood treatment device operates in a first operating mode in which a dialysate outlet valve is open such that dialysate flows through a dialyzer feed line, through a dialysate chamber, and into and through a dialyzer discharge line. The extracorporeal blood treatment device operates in a second operating mode to remove the secondary membrane from the semipermeable membrane. During the second operating mode, the dialysate outlet valve is closed for a duration of time such that dialysate is prevented from flowing through the dialyzer discharge line. A backflush procedure results wherein a volume of dialysate passes from the dialysate chamber through the semipermeable membrane and into the blood chamber.
    Type: Application
    Filed: March 28, 2022
    Publication date: November 24, 2022
    Applicant: Fresenius Medical Care Holdings, Inc.
    Inventors: Matthew Doyle, Robert Anthony Zimmerman
  • Patent number: 11504458
    Abstract: A system for blood treatment can include a dialysis machine and an ultrasonic authentication device connected to the blood treatment machine, the ultrasonic authentication device configured to scan a label and send signals containing label information to the dialysis machine.
    Type: Grant
    Filed: October 7, 2019
    Date of Patent: November 22, 2022
    Assignee: Fresenius Medical Care Holdings, Inc.
    Inventor: Martin Joseph Crnkovich
  • Patent number: 11504519
    Abstract: The present teachings may generally include a sealing device disposed within a connector (e.g., a patient connector) at an end of catheter tubing, where the sealing device is structurally configured to form a releasable seal for the catheter tubing. That is, when unengaged with a contact portion of another connector or device, the sealing device may be disposed in a first position establishing the seal. Specifically, a channel disposed through a body of the sealing device may be obstructed when in the first position. However, through predetermined engagement with the contact portion of another connector or device, the sealing device may be moved (e.g., rotated) to a second position to establish a fluid pathway through the channel. And, when the predetermined engagement is removed, the sealing device may be structurally configured to automatically move back into the first position to reestablish the seal for the catheter tubing.
    Type: Grant
    Filed: September 2, 2020
    Date of Patent: November 22, 2022
    Assignee: Fresenius Medical Care Holdings, Inc.
    Inventors: Orestes Soto Ramirez, Irving Uziel Hernandez Gomez
  • Publication number: 20220362717
    Abstract: The present invention relates to a method to make polymeric membranes that are preferably useful in dialysis, wherein the method conducts at least one membrane-forming step and/or post-forming processing step with the use of sonication. Polymeric membrane, such as polymeric hollow fiber membrane, having improved one or properties are further described.
    Type: Application
    Filed: May 10, 2022
    Publication date: November 17, 2022
    Applicant: Fresenius Medical Care Holdings, Inc.
    Inventors: Brodie SCHWINN, Jiunn TEO
  • Patent number: 11499016
    Abstract: A polysulfone-urethane copolymer is disclosed, which can be used as a membrane polymer, e.g., a matrix polymer, a pore forming agent, or both, while enhancing a membrane's blood compatibility. Methods are disclosed for forming the copolymer and incorporating the copolymer in membranes (e.g., spun hollow fibers, flat membranes) and other products.
    Type: Grant
    Filed: October 1, 2020
    Date of Patent: November 15, 2022
    Assignee: FRESENIUS MEDICAL CARE HOLDINGS, INC.
    Inventors: Geoffrey Russell, James White, Jiunn Teo, Kevin Hudson, Monica Hall, Praveen Kosaraju
  • Patent number: 11500400
    Abstract: In one aspect, a valve actuation system includes a drive unit including an actuator configured to engage and move multiple valves disposed within a fluid cassette to selectively open and close each valve of the multiple valves and a positioning frame disposed adjacent the fluid cassette and along which the drive unit can be moved in three dimensions to align the actuator with a selected valve of the multiple valves.
    Type: Grant
    Filed: July 23, 2019
    Date of Patent: November 15, 2022
    Assignee: Fresenius Medical Care Holdings, Inc.
    Inventors: Lynn E. Jensen, Philip Scott James
  • Patent number: 11495359
    Abstract: A method and system for determining a patient's risk of developing an infection is disclosed. In one embodiment, the system and method includes extracting patient data from one or more databases corresponding to a pool of patients receiving treatment; using one or more predictive models with the extracted patient data to generate, for each of the patients in the pool of patients, a respective patient risk score for developing an infection within a selected time period; generating a report including at least a portion of the identified subset of the pool of patients and their respective patient risk scores; and transmitting the report to one or more health care facilities, the one or more health care facilities further identifying one or more patients from the portion of the identified subset of the pool of patients for interventional treatment, consultation, training, or combinations thereof.
    Type: Grant
    Filed: June 28, 2019
    Date of Patent: November 8, 2022
    Assignee: FRESENIUS MEDICAL CARE HOLDINGS, INC.
    Inventors: Thomas C. Blanchard, Len Usvyat, Joanna L. Willetts, Melissa C. Herman, Brian C. Ellison, Judith E. Moran, Dinesh K. Chatoth
  • Patent number: 11491267
    Abstract: A method of dialysis is provided that includes sensing the concentration of potassium in a patient's blood serum, in used dialysate resulting from treating the patient, or in both. The method involves generating a sensed value of the concentration of potassium, comparing the sensed value with one or more values stored in a memory, and generating a control signal based on the comparison. Supplemental potassium solution is infused into the treatment dialysate, based on the control signal. The comparison can be made to patient-historical data, population data, or both.
    Type: Grant
    Filed: July 24, 2019
    Date of Patent: November 8, 2022
    Assignee: FRESENIUS MEDICAL CARE HOLDINGS, INC.
    Inventors: Stephen Merchant, Roland Levin, Chris Chau, Shakil Aslam
  • Patent number: 11491270
    Abstract: A dialysis system includes include a home dialysis machine and a home gateway device in communication with a cloud-based application via a connected health system. The gateway device has voice recognition capabilities. A user can provide spoken information to the gateway device, and the gateway device can cause one or more actions to be performed. The gateway device may cause a dialysis function to be performed by the dialysis machine, or data to be input into the dialysis machine. The gateway device can also communicate with one or more other systems (e.g., remote systems) via the cloud-based application. In some examples, the cloud-based application can communicate with an order management system to allow the user to order medical supplies (e.g., for use with the dialysis machine) via the gateway device. The gateway device can provide two-way conversational capability (e.g., back and forth communication) between the user and the gateway device.
    Type: Grant
    Filed: January 5, 2018
    Date of Patent: November 8, 2022
    Assignee: Fresenius Medical Care Holdings, Inc.
    Inventors: Matthew Buraczenski, Harvey Cohen, Kulwinder S. Plahey, John A. Biewer
  • Patent number: 11491269
    Abstract: The disclosed arterial chambers for hemodialysis may include a cap with a blood inlet port for conveying an intended patient's blood into the arterial chamber, an auxiliary port configured to provide fluid access to the arterial chamber, and a needleless access port configured to couple to a needleless syringe. The needleless access port may be configured for administering a substance to an interior of the arterial chamber from the needleless syringe and/or for withdrawing blood from the interior of the arterial chamber into the needleless syringe. Various tubing sets, hemodialysis systems, and other components, systems, and methods are also disclosed.
    Type: Grant
    Filed: January 21, 2020
    Date of Patent: November 8, 2022
    Assignee: Fresenius Medical Care Holdings, Inc.
    Inventors: Irving Uziel Hernandez Gomez, Juan Arturo Montecillo Juárez, Diego Suarez del Real Pena
  • Patent number: 11484636
    Abstract: A medical device, such as a dialysis machine, may have multiple features and components that must be checked and attached prior to a treatment, and operators often lay tubing and other components on a surface after removing them from packaging. The system described herein provides a sterile work platform that is integrated with the medical device. In an example, the platform may be moveably coupled to the medical device. In a first position, the platform is positioned within or against the medical device, and, in a second position, the platform is extended from the medical device and disposed in a horizontal position. After the platform is extended to the second position, a surface of the platform is sterile and suitable to maintain aseptic technique for tubing and components placed on the platform. An information screen may be integrated into the platform and that provides information to an operator.
    Type: Grant
    Filed: April 16, 2020
    Date of Patent: November 1, 2022
    Assignee: Fresenius Medical Care Holdings, Inc.
    Inventors: Eric Bergman, David Yuds, Jonathan Leclerc, Mary Vasseur Finn
  • Patent number: 11478578
    Abstract: This disclosure relates to medical fluid cassettes and related systems and methods. In certain aspects, a medical fluid cassette includes a base having a first region and a second region, a first membrane overlying the first region of the base, and a second membrane overlying the second region of the base. The second membrane is configured to rebound away from the base when a force used to press the second membrane toward the base is released.
    Type: Grant
    Filed: September 23, 2019
    Date of Patent: October 25, 2022
    Assignee: Fresenius Medical Care Holdings, Inc.
    Inventors: Sean Farrell, Joseph Michael Fallon, Kulwinder S. Plahey, Michael James Beiriger
  • Patent number: 11479397
    Abstract: The disclosed packaging bags may include a flexible front sidewall and a flexible rear sidewall with at least a first closed edge, second closed edge, and third closed edge coupling the front sidewall to the rear sidewall. A perforation may be formed through the flexible front sidewall and the flexible rear sidewall along the first closed edge. The perforation may extend in a first segment from the first closed edge toward a central region of the packaging bag, in a second segment in a direction along the first closed edge, and in a third segment back to the first closed edge. The second segment may include at least one elongated ventilation slit. Various other related packaging bags and methods are also disclosed.
    Type: Grant
    Filed: December 1, 2020
    Date of Patent: October 25, 2022
    Assignee: Fresenius Medical Care Holdings, Inc.
    Inventors: Diego Suarez del Real Pena, Jose Eduardo Pena Martinez
  • Patent number: 11481105
    Abstract: A networked dialysis system includes a dialysis machine, a user interface, and a device that is located remotely from the dialysis machine and that exchanges information with the dialysis machine via a networked communications link. A digital data processor, which is coupled to the dialysis machine and to the remote device, facilitates execution of services on one or more remote digital data processing systems. The digital data processor is coupled to the remote device via the networked communications link and is coupled to the dialysis machine via a second communications link.
    Type: Grant
    Filed: October 20, 2020
    Date of Patent: October 25, 2022
    Assignee: FRESENIUS MEDICAL CARE HOLDINGS, INC.
    Inventors: Fei Wang, Martin Crnkovich
  • Patent number: 11471578
    Abstract: Systems, methods, and/or apparatuses may be operative to perform a dialysis process that includes a displacer infusion process. The dialysis machine may include at least one processor and a memory coupled to the at least one processor, the memory comprising instructions that, when executed by the processor, may cause the at least one processor to access dialysis information for a dialysis process performed by a dialysis machine, the dialysis information indicating a target substance to be displaced from a binding compound by a displacer, and determine an infusion profile for infusing the displacer into a patient during a displacer infusion process of the dialysis process, the infusion profile determined based on the dialysis information and an infusion constraint. Other embodiments are described.
    Type: Grant
    Filed: April 18, 2019
    Date of Patent: October 18, 2022
    Assignee: FRESENIUS MEDICAL CARE HOLDINGS, INC.
    Inventors: Vaibhav Maheshwari, Peter Kotanko
  • Publication number: 20220308586
    Abstract: A delivery robot is provided for the delivery of home dialysis supplies to a home dwelling of a home dialysis patient. The delivery robot can be an autonomous delivery robot. The delivery robot can have an outdoor set of wheels or other traction devices, and an indoor set of wheels or other traction devices. The delivery robot can be configured to switch between an outdoor configuration for traversing an outdoor surface, and an indoor configuration for traversing an inside surface, inside the home of the home dialysis patient. A network is also provided and can include a robot delivery vehicle, a warehouse, a remote computer within the patient's home, or a combination thereof. Methods of delivering home dialysis supplies are also provided that utilize the delivery robot and network.
    Type: Application
    Filed: March 24, 2021
    Publication date: September 29, 2022
    Applicant: Fresenius Medical Care Holdings, Inc.
    Inventors: Eric Bergman, Jessica Steuber, David Yuds, Jonathan Leclerc